Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
ConclusionsSOT recipients had a high allograft rejection rate that was observed shortly after CPI initiation, with high mortality rates. Further studies are needed to optimize the anticancer treatment approach in these patients.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Bone Graft | Cancer | Cancer & Oncology | Clinical Trials | Databases & Libraries | Immunotherapy | Melanoma | Skin Cancer | Study | Texas University | Transplants